Cathy Burgess, partner in Alston & Bird’s Food, Drug & Device / FDA Group, has been elected to a four-year term on the board of directors of the Food and Drug Law Institute (FDLI), effective January 1, 2019.
FDLI board members are chosen for their exceptional professional accomplishments and proven commitment to the food and drug law field.
Burgess focuses her practice on regulatory compliance, product risk management, enforcement, and policy matters affecting industries regulated by the U.S. Food and Drug Administration.
Founded in 1949, the Food and Drug Law Institute is a nonprofit membership organization that offers education, training, publications, and professional networking opportunities in the field of food and drug law.
FDLI board members are chosen for their exceptional professional accomplishments and proven commitment to the food and drug law field.
Burgess focuses her practice on regulatory compliance, product risk management, enforcement, and policy matters affecting industries regulated by the U.S. Food and Drug Administration.
Founded in 1949, the Food and Drug Law Institute is a nonprofit membership organization that offers education, training, publications, and professional networking opportunities in the field of food and drug law.